#EULAR2022 OP0071 Association between long-term exposure to air pollution (fine particulate matter) and immune-mediated disease in Italy ⭐️⬆️ risk of autoimmune disease, esp RA as well as CTD, IBD ⭐️Every 10 ug/m3 increase in PM, associated with incremental 7% risk @RheumNow https://t.co/x57CXUHSHb

NORD-STAR substudy of coagulation and fibrinolytic parameters: 〽️Impairement in eRA ⚡️Biologic parameters restored by ttmt. Effect seemed ▶️ with Biologic vs. MTX + GCs ❕No adjustment on disease activity #OP0059 #EULAR2022 @RheumNow https://t.co/CJHldOimBn

🚨 Depression = major comorbidity! DANBIO register 10000+ patients: ❗️10% prescription antidepressants💊 ❗️Cumulative mortality ⬆️ w/ OR>6 ❗️Particularly in age group <55 #OP0067 #EULAR2022 @RheumNow https://t.co/le8VWBFjPK

Have always been fascinated by the idea that some b/tsDMARDs might have effects on pain and fatigue beyond inflammation control. Baricitinib data in RA before, & now this from guselkumab. Substantial effect on pain beyond SJC/CRP attributable? POS1030 #EULAR2022 #IL23 @RheumNow https://t.co/fxqIGnlkwU

#EULAR OP0072: SMILE: Self-Management Individualised Learning Environment for RA 😀5 modules, with 3-4 more planned in 2022 😀Learning objectives 😀Plan to target resources to questionnaire @RheumNow

More from the VITAL study Dr Costenbader @karen_kc123 et al. 5 year supplementation followed 2 year follow up. Vit D 2000iu ⬇️incident autoimmune disease 21%. RA, PMR, psoriasis trend towards reduction. No effect omega-3 @RheumNow #EULAR2022 OP0038 https://t.co/kbKqDhtN9z https://t.co/HcFXbweEPm

• EULAR Abstract Archive